$THRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Innoviva, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Innoviva, Inc.. Get notifications about new insider transactions in Innoviva, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 ... 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 40.03 | 22,353 | 894,791 | 690,106 | 712.5 K to 690.1 K (-3.14 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 35.89 | 10,046 | 360,551 | 712,459 | 722.5 K to 712.5 K (-1.39 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 35.89 | 3,773 | 135,413 | 304,643 | 308.4 K to 304.6 K (-1.22 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 16.00 | 18,750 | 300,000 | 0 | |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 16.00 | 18,750 | 300,000 | 226,642 | 207.9 K to 226.6 K (+9.02 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 35.89 | 3,813 | 136,849 | 207,892 | 211.7 K to 207.9 K (-1.80 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 35.89 | 4,570 | 164,017 | 138,346 | 142.9 K to 138.3 K (-3.20 %) |
| Aug 01 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 36.51 | 7,000 | 255,570 | 211,705 | 218.7 K to 211.7 K (-3.20 %) |
| Aug 01 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 100,000,000.00 | 3,064,407 | 306,440,699,999,690 | 29,785,600 | 26.7 M to 29.8 M (+11.47 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 722,505 | 711.5 K to 722.5 K (+1.55 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 5,000 | 0 | 308,416 | 303.4 K to 308.4 K (+1.65 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 218,705 | 213.7 K to 218.7 K (+2.34 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 5,000 | 0 | 291,094 | 286.1 K to 291.1 K (+1.75 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 5,000 | 0 | 142,916 | 137.9 K to 142.9 K (+3.63 %) |
| Jun 11 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Sell | S | 35.04 | 31,038 | 1,087,572 | 303,416 | 334.5 K to 303.4 K (-9.28 %) |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 12.40 | 6,451 | 79,992 | 0 | |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 4,570 | 14,167 | 0 | |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 12.40 | 6,451 | 79,992 | 213,705 | 207.3 K to 213.7 K (+3.11 %) |
| May 31 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 4,570 | 14,167 | 207,254 | 202.7 K to 207.3 K (+2.25 %) |
| May 31 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 35.01 | 3,808 | 133,318 | 48,749 | 52.6 K to 48.7 K (-7.25 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 37.01 | 10,046 | 371,802 | 711,505 | 721.6 K to 711.5 K (-1.39 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 37.01 | 3,292 | 121,837 | 334,454 | 337.7 K to 334.5 K (-0.97 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 37.01 | 3,292 | 121,837 | 202,684 | 206 K to 202.7 K (-1.60 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Payment of Exercise | F | 37.01 | 2,443 | 90,415 | 52,557 | 55 K to 52.6 K (-4.44 %) |
| May 22 2013 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 37.01 | 3,292 | 121,837 | 286,094 | 289.4 K to 286.1 K (-1.14 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 37.01 | 4,570 | 169,136 | 137,916 | 142.5 K to 137.9 K (-3.21 %) |
| May 15 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Option Exercise | M | 34.00 | 16,129 | 548,386 | 0 | |
| May 15 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 40.33 | 16,129 | 650,483 | 55,000 | 71.1 K to 55 K (-22.68 %) |
| May 15 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Buy | M | 34.00 | 16,129 | 548,386 | 71,129 | 55 K to 71.1 K (+29.33 %) |
| May 07 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Option Exercise | M | 29.65 | 16,129 | 478,225 | 0 | |
| May 07 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 34.77 | 16,129 | 560,805 | 55,000 | 71.1 K to 55 K (-22.68 %) |
| May 07 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Buy | M | 29.65 | 16,129 | 478,225 | 71,129 | 55 K to 71.1 K (+29.33 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 34.34 | 200 | 6,868 | 205,976 | 206.2 K to 206 K (-0.10 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 33.72 | 6,800 | 229,296 | 206,176 | 213 K to 206.2 K (-3.19 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Option Exercise | M | 17.91 | 170,879 | 3,060,443 | 0 | |
| May 02 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 34.34 | 10,100 | 346,834 | 142,486 | 152.6 K to 142.5 K (-6.62 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 33.77 | 160,779 | 5,429,507 | 152,586 | 313.4 K to 152.6 K (-51.31 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Buy | M | 17.91 | 170,879 | 3,060,443 | 313,365 | 142.5 K to 313.4 K (+119.93 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Option Exercise | M | 6.15 | 8,333 | 51,248 | 0 | |
| May 02 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 34.35 | 100 | 3,435 | 55,000 | 55.1 K to 55 K (-0.18 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 33.76 | 17,004 | 574,055 | 55,100 | 72.1 K to 55.1 K (-23.58 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Buy | M | 6.15 | 8,333 | 51,248 | 72,104 | 63.8 K to 72.1 K (+13.07 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 9.69 | 385,161 | 3,731,247 | 0 | |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 34.32 | 1,577 | 54,123 | 721,551 | 723.1 K to 721.6 K (-0.22 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 33.64 | 253,955 | 8,543,046 | 723,128 | 977.1 K to 723.1 K (-25.99 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 9.69 | 385,161 | 3,731,247 | 977,083 | 591.9 K to 977.1 K (+65.07 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 52,129 | 46.1 K to 52.1 K (+13.01 %) |
| Apr 30 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 6,699,220.00 | 193,563 | 1,296,720,236,277 | 26,721,193 | 26.5 M to 26.7 M (+0.73 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 6,000 | 0 | 574,571 | 568.6 K to 574.6 K (+1.06 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Grant | A | 0.00 | 6,000 | 0 | 68,258 | 62.3 K to 68.3 K (+9.64 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 30,000 | 24 K to 30 K (+25.00 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Grant | A | 0.00 | 6,000 | 0 | 85,988 | 80 K to 86 K (+7.50 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Grant | A | 0.00 | 6,000 | 0 | 36,000 | 30 K to 36 K (+20.00 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Grant | A | 0.00 | 6,000 | 0 | 84,164 | 78.2 K to 84.2 K (+7.68 %) |
| Apr 26 2013 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Option Exercise | A | 30.54 | 6,000 | 183,240 | 6,000 | |
| Apr 26 2013 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Grant | A | 0.00 | 6,000 | 0 | 27,000 | 21 K to 27 K (+28.57 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 22.10 | 10,655 | 235,476 | 591,922 | 602.6 K to 591.9 K (-1.77 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 22.14 | 7,000 | 154,980 | 212,976 | 220 K to 213 K (-3.18 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.10 | 5,002 | 110,544 | 219,976 | 225 K to 220 K (-2.22 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 22.10 | 5,004 | 110,588 | 337,746 | 342.8 K to 337.7 K (-1.46 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Payment of Exercise | F | 22.10 | 3,416 | 75,494 | 63,771 | 67.2 K to 63.8 K (-5.08 %) |
| Feb 20 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 2,567,090.00 | 116,527 | 299,135,274,290 | 26,527,630 | 26.4 M to 26.5 M (+0.44 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 602,577 | 591.6 K to 602.6 K (+1.86 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 5,000 | 0 | 342,750 | 337.8 K to 342.8 K (+1.48 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 224,978 | 220 K to 225 K (+2.27 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Grant | A | 0.00 | 5,000 | 0 | 67,187 | 62.2 K to 67.2 K (+8.04 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 5,000 | 0 | 289,386 | 284.4 K to 289.4 K (+1.76 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 5,000 | 0 | 142,486 | 137.5 K to 142.5 K (+3.64 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 2,655 | 8,231 | 0 | |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 11,855 | 36,751 | 0 | |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Gift | G | 0.00 | 460 | 0 | 219,978 | 220.4 K to 220 K (-0.21 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 2,655 | 8,231 | 220,438 | 217.8 K to 220.4 K (+1.22 %) |
| Jan 14 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 11,855 | 36,751 | 217,783 | 205.9 K to 217.8 K (+5.76 %) |
| Nov 20 2012 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 21.08 | 4,874 | 102,744 | 337,750 | 342.6 K to 337.8 K (-1.42 %) |
| Nov 20 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 21.08 | 4,874 | 102,744 | 205,928 | 210.8 K to 205.9 K (-2.31 %) |
| Nov 20 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Payment of Exercise | F | 21.08 | 3,054 | 64,378 | 62,187 | 65.2 K to 62.2 K (-4.68 %) |
| Nov 16 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 3.10 | 5,161 | 15,999 | 0 | |
| Nov 16 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 3.10 | 5,161 | 15,999 | 210,802 | 205.6 K to 210.8 K (+2.51 %) |
| Nov 06 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 22.53 | 200 | 4,506 | 205,641 | 205.8 K to 205.6 K (-0.10 %) |
| Nov 06 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 21.42 | 6,800 | 145,656 | 205,841 | 212.6 K to 205.8 K (-3.20 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 5,000 | 0 | 342,624 | 337.6 K to 342.6 K (+1.48 %) |
| Nov 05 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 6,265,780.00 | 280,348 | 1,756,598,274,674 | 26,411,103 | 26.1 M to 26.4 M (+1.07 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 591,577 | 580.6 K to 591.6 K (+1.89 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 5,000 | 0 | 212,641 | 207.6 K to 212.6 K (+2.41 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Grant | A | 0.00 | 5,000 | 0 | 65,241 | 60.2 K to 65.2 K (+8.30 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 5,000 | 0 | 284,386 | 279.4 K to 284.4 K (+1.79 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 5,000 | 0 | 137,486 | 132.5 K to 137.5 K (+3.77 %) |
| Aug 28 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 27.50 | 3,483 | 95,783 | 60,241 | 63.7 K to 60.2 K (-5.47 %) |
| Aug 28 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Option Exercise | M | 17.91 | 4,121 | 73,807 | 170,879 | |
| Aug 28 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 27.86 | 2,861 | 79,707 | 132,486 | 135.3 K to 132.5 K (-2.11 %) |
| Aug 28 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 27.24 | 17,700 | 482,148 | 135,347 | 153 K to 135.3 K (-11.57 %) |
| Aug 28 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 28.01 | 4,121 | 115,429 | 153,047 | 157.2 K to 153 K (-2.62 %) |
| Aug 28 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Buy | M | 17.91 | 4,121 | 73,807 | 157,168 | 153 K to 157.2 K (+2.69 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 27.01 | 10,681 | 288,494 | 580,577 | 591.3 K to 580.6 K (-1.81 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 27.01 | 4,596 | 124,138 | 337,624 | 342.2 K to 337.6 K (-1.34 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 27.01 | 4,644 | 125,434 | 207,641 | 212.3 K to 207.6 K (-2.19 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Payment of Exercise | F | 27.01 | 3,057 | 82,570 | 63,724 | 66.8 K to 63.7 K (-4.58 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 27.01 | 4,877 | 131,728 | 153,047 | 157.9 K to 153 K (-3.09 %) |
| Aug 15 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 26.15 | 3,108 | 81,274 | 212,285 | 215.4 K to 212.3 K (-1.44 %) |
| Aug 15 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 25.68 | 21,892 | 562,187 | 215,393 | 237.3 K to 215.4 K (-9.23 %) |
| Aug 09 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Option Exercise | M | 16.25 | 60,000 | 975,000 | 0 | |
| Aug 09 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 27.04 | 60,000 | 1,622,400 | 157,924 | 217.9 K to 157.9 K (-27.53 %) |
| Aug 09 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Buy | M | 16.25 | 60,000 | 975,000 | 217,924 | 157.9 K to 217.9 K (+37.99 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Option Exercise | M | 18.37 | 15,090 | 277,203 | 0 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Option Exercise | M | 6.15 | 91,667 | 563,752 | 8,333 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Sell | S | 27.92 | 123,917 | 3,459,763 | 66,781 | 190.7 K to 66.8 K (-64.98 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Buy | M | 18.37 | 15,090 | 277,203 | 190,698 | 175.6 K to 190.7 K (+8.59 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Buy | M | 6.15 | 91,667 | 563,752 | 175,608 | 83.9 K to 175.6 K (+109.20 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 64,516 | 200,000 | 0 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 80,645 | 250,000 | 0 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 28.15 | 36,200 | 1,019,030 | 591,258 | 627.5 K to 591.3 K (-5.77 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 27.77 | 39,549 | 1,098,276 | 627,458 | 667 K to 627.5 K (-5.93 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 64,516 | 200,000 | 667,007 | 602.5 K to 667 K (+10.71 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 80,645 | 250,000 | 602,491 | 521.8 K to 602.5 K (+15.45 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 28.21 | 316,334 | 8,923,782 | 26,130,755 | 25.8 M to 26.1 M (+1.23 %) |
| Aug 01 2012 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 29.69 | 7,546 | 224,041 | 279,386 | 286.9 K to 279.4 K (-2.63 %) |
| May 31 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Sell | S | 22.29 | 20,000 | 445,800 | 157,924 | 177.9 K to 157.9 K (-11.24 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 20.33 | 3,832 | 77,905 | 342,220 | 346.1 K to 342.2 K (-1.11 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 20.33 | 3,832 | 77,905 | 237,285 | 241.1 K to 237.3 K (-1.59 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Brinkley David L | Head of Business De ... | Payment of Exercise | F | 20.33 | 2,402 | 48,833 | 83,941 | 86.3 K to 83.9 K (-2.78 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 20.33 | 3,832 | 77,905 | 177,924 | 181.8 K to 177.9 K (-2.11 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 20.33 | 10,681 | 217,145 | 521,846 | 532.5 K to 521.8 K (-2.01 %) |
| May 17 2012 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 46,129 | 40.1 K to 46.1 K (+14.95 %) |
| May 17 2012 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 6,000 | 0 | 568,571 | 562.6 K to 568.6 K (+1.07 %) |
| May 17 2012 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Grant | A | 0.00 | 6,000 | 0 | 62,258 | 56.3 K to 62.3 K (+10.67 %) |
| May 17 2012 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 24,000 | 18 K to 24 K (+33.33 %) |
| May 17 2012 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Grant | A | 0.00 | 6,000 | 0 | 30,000 | 24 K to 30 K (+25.00 %) |
| May 17 2012 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Grant | A | 0.00 | 6,000 | 0 | 79,988 | 74 K to 80 K (+8.11 %) |
| May 17 2012 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Grant | A | 0.00 | 6,000 | 0 | 78,164 | 72.2 K to 78.2 K (+8.31 %) |
| May 17 2012 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Option Exercise | A | 21.62 | 6,000 | 129,720 | 6,000 | |
| May 17 2012 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Grant | A | 0.00 | 6,000 | 0 | 21,000 | 15 K to 21 K (+40.00 %) |
| May 16 2012 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 21.29 | 10,000,000 | 212,887,000 | 25,814,421 | 15.8 M to 25.8 M (+63.23 %) |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 9.69 | 30,967 | 300,070 | 0 | |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 32,258 | 100,000 | 0 | |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 9.69 | 30,967 | 300,070 | 532,527 | 501.6 K to 532.5 K (+6.17 %) |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 32,258 | 100,000 | 501,560 | 469.3 K to 501.6 K (+6.87 %) |